Market research
29C1.F CareRx Corporation
F EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 122M
- P/E ratio
- 7.42
- Analyst target
- Not available
- Dividend yield
- 4.2%
- Beta
- 0.6
Community
Investor discussion
1 comment
Sign in to join the 29C1.F discussion.
5 years, 5 months ago
CareRx Corporation is currently in a long term uptrend where the price is trading 36.5% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.6.
CareRx Corporation's total revenue rose by 44.0% to $46M since the same quarter in the previous year.
Its net income has increased by 84.0% to $-3M since the same quarter in the previous year.
Finally, its free cash flow grew by 86.6% to $2M since the same quarter in the previous year.
Based on the above factors, CareRx Corporation gets an overall score of 5/5.